Lixte Biotechnology Holdings, Inc.
USD7.21
-0.46 (-6.00%)
CEO
Geordan G. Pursglove
IPO Date
2007-10-25
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$7.81
Prev. Close
$7.67
Day Low
$7.00
Day High
$7.95
52W Low
$2.02
52W High
$8.38
Market Cap
$0.09B
Volume
0.62M
| 40,000 |
| $0.00 |
| 2 Jul 2026 | Pursglove Geordan Garrett | director, officer: CEO and Chairman of the Board | A-Award | Acquired | 350,000 | $0.00 |
| 2 Jul 2026 | Primus Guy Warren | director | A-Award | Acquired | 15,000 | $0.00 |
| 2 Jul 2026 | Holloway Michael Andrew | director | A-Award | Acquired | 15,000 | $0.00 |
| 2 Jul 2026 | Felix Lourdes | director | A-Award | Acquired | 30,000 | $0.00 |
| 2 Jul 2026 | Travaglini John Francis | director: | Disposed | 0 | $0.00 |
| 1 Jun 2026 | Porter Stuart D | director | A-Award | Acquired | 25,000 | $0.00 |
| 1 Jun 2026 | Porter Stuart D | director: | Disposed | 0 | $0.00 |
| 17 Apr 2026 | Pursglove Geordan Garrett | director, officer: CEO and Chairman of the Board | A-Award | Acquired | 350,000 | $0.00 |